Completed PHASE1 INTERVENTIONAL 2-arm
NCT06625814
A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028)
A Clinical Study to Evaluate the Effect of MK-0616 on the Pharmacokinetics of Levothyroxine in Healthy Adult Participants
Sponsor: Celerion
Conditions
Healthy
Interventions
Enlicitide Decanoate Levothyroxine
Updated 1 time since 2024 Last updated: Oct 1, 2024 Started: Jul 8, 2024 Primary completion: Aug 19, 2024 Completion: Sep 11, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06625814, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Celerion, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Celerion
- Merck Sharp & Dohme LLC
Data source: Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .